Category: Professional Posters
Purpose: Communicate Pfizer’s commitment to pharmacist talent development and retention, through participation in post-doctoral fellowship programs in collaboration with various institutions – Rutgers University Ernest Mario School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences (MCPHS) University, and University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Science. The aim of the Pfizer Post-Doctoral Industry Fellowship program is to prepare pharmacy graduates for careers in the biopharmaceutical industry. Through 1- or 2-year project assignments, fellows further their understanding of the pharmaceutical industry, develop core required capabilities, enhance technical skillsets, and expand their professional networks.
Methods: A pooled analysis was conducted evaluating the retention rate of post-doctoral Pharmacy fellows within Pfizer, using data from 2009 to 2019. To be included in this analysis, fellows were required to be recruited through the formal process, be affiliated with one of the three schools’ programs, and have successfully completed their 1- or 2-year fellowship within the reporting period. The analysis excluded data from fellows that initially accepted the offering but did not complete the full term of the assignment. Additionally, the analysis excluded current fellows that have not yet completed the full term, and new fellows beginning their assignments in 2019.
Retention rate is reported as a percentage of the number of fellows that were offered a position at Pfizer upon successful completion of their fellowship versus the total number of fellows completing their assignment during the reporting period.
Results: A total of 62 potential fellowship completions were identified during the reporting period. Of those, 57 were included in the final analysis. Five fellows did not complete their assignments due to securing alternate permanent industry roles (n=3), or for personal reasons (n=2).
Of the 57 fellows included in the analysis, 22 completed a 1-year fellowship assignment, while 35 completed a 2-year assignment. Assignments spanned multiple functional groups including Medical Affairs (n=25), Clinical Pharmacology (n=10), Clinical Research (n=8), Clinical Supply Chain (n=7), Quality Assurance (n=2), Medical Affairs/Medical Information (n=2), Marketing & Commercial Development (n=1), Regulatory Affairs (n=1), and Global Health & Value (n=1).
Upon completion of the fellowship, 51% (29 out of 57) of fellows accepted permanent roles at Pfizer. Of the 29 fellows – 10 had completed a 1-year fellowship, while 19 had completed a 2-year fellowship. Retention rate in the department where the fellowship originated was 72% (21 out of 29). The remaining 28 fellow graduates accepted roles elsewhere - 46% (26 out of 57) accepted roles in other pharmaceutical companies and 3% (2 out of 57) accepted roles in other areas.
Conclusion: Pfizer’s commitment to pharmacist talent development is evident through the support of the Post-Doctoral Industry Fellowship program. For more than a decade, the program has offered fellows a wide array of experiences, across multiple functions; thereby enhancing their skillsets in support of advancing the business. Successful completion of the program, along with availability of permanent offerings, is correlated with high talent retention rates at Pfizer, especially in the department of original assignment.